These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 17403939)
1. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy. Lee WC; Tsoi YK; Troendle FJ; DeLucia MW; Ahmed Z; Dicky CA; Dickson DW; Eckman CB FASEB J; 2007 Aug; 21(10):2520-7. PubMed ID: 17403939 [TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy. Lee WC; Courtenay A; Troendle FJ; Stallings-Mann ML; Dickey CA; DeLucia MW; Dickson DW; Eckman CB FASEB J; 2005 Sep; 19(11):1549-51. PubMed ID: 15987783 [TBL] [Abstract][Full Text] [Related]
3. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520 [TBL] [Abstract][Full Text] [Related]
4. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model. Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749 [TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy. Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830 [TBL] [Abstract][Full Text] [Related]
6. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease). Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188 [TBL] [Abstract][Full Text] [Related]
7. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features. Rafi MA; Rao HZ; Luzi P; Luddi A; Curtis MT; Wenger DA Mol Genet Metab; 2015 Mar; 114(3):459-66. PubMed ID: 25533112 [TBL] [Abstract][Full Text] [Related]
8. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy. Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770 [TBL] [Abstract][Full Text] [Related]
9. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Shen JS; Watabe K; Ohashi T; Eto Y Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455 [TBL] [Abstract][Full Text] [Related]
10. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012 [TBL] [Abstract][Full Text] [Related]
11. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD). Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875 [TBL] [Abstract][Full Text] [Related]
12. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo. Meng XL; Shen JS; Watabe K; Ohashi T; Eto Y Mol Genet Metab; 2005 Apr; 84(4):332-43. PubMed ID: 15781194 [TBL] [Abstract][Full Text] [Related]
13. Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cells. Strazza M; Luddi A; Carbone M; Rafi MA; Costantino-Ceccarini E; Wenger DA Mol Genet Metab; 2009 May; 97(1):27-34. PubMed ID: 19217332 [TBL] [Abstract][Full Text] [Related]
14. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease. Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551 [TBL] [Abstract][Full Text] [Related]
15. Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy. Luddi A; Strazza M; Carbone M; Moretti E; Costantino-Ceccarini E Exp Cell Res; 2005 Mar; 304(1):59-68. PubMed ID: 15707574 [TBL] [Abstract][Full Text] [Related]
18. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant. Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599 [TBL] [Abstract][Full Text] [Related]
19. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers. Victoria T; Rafi MA; Wenger DA Genomics; 1996 May; 33(3):457-62. PubMed ID: 8661004 [TBL] [Abstract][Full Text] [Related]
20. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy. Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]